Oslo Cancer Cluster and NCE Smart Energy Markets, together with four European clusters in medicine and IT, landed a prestigious Horizon 2020 EU project. The project will use innovative IT solutions to develop personalized cancer treatment.

Allocated funds are 45 million NOK, of which 34 million NOK are earmarked for small and medium enterprises in the clusters.

Download PERMIDES Flyer

  • Participants

    • Oslo Cancer Cluster S.A (NO)
    • NCE Smart Energy Markets, c/o Smart Innovation Østfold AS (NO)
    • Software-Cluster c/o CyberForum e.V. (DE)
    • Cluster für Individualisierte ImmunIntervention (Ci3) e.V. (DE)
    • intelligent views GmbH (DE)
    • NETSYNO Software GmbH (DE)
    • Oncotyrol – Center for Personalized Cancer Medicine GmbH (AT)
    • IT-Cluster – Business Upper Austria, OÖ Wirtschaftsagentur GmbH (AT)

The EU project with the sounding name “Personalized Medicine Innovation through Digital Enterprise Solutions: PERMIDES”, will utilize digital tools and novel solutions from the IT sector to support the development of new cancer treatment. This will be achieved by matching small and medium enterprises from the IT and the biopharma sector for joint innovation projects.

PERMIDES ends in 2018, and has ambitious goals:

      • 90 innovation projects between IT and biotechs with funding through an innovation voucher system
      • 120 IT companies and biotech companies have benefited from technology transfer activities
      • 75 enterprises have participated in networking conferences at regional and European level
      • 100 companies have placed their profile in a semantic matchmaking portal – the PERMIDES platform